Skip to content
healthcare.dev

Gabapentin

NDC 53746-102, Gabapentin, capsule, from Amneal Pharmaceuticals of New York LLC.

Product NDC
53746-102
Status
Listed
Labeler
Amneal Pharmaceuticals of New York LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078428
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53746-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GABAPENTIN300 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
53746-102-0153746010201100 CAPSULE in 1 BOTTLE (53746-102-01)
53746-102-0553746010205500 CAPSULE in 1 BOTTLE (53746-102-05)
53746-102-10537460102101000 CAPSULE in 1 BOTTLE (53746-102-10)
53746-102-305374601023030 CAPSULE in 1 BOTTLE (53746-102-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b11dbff5-ceee-4a63-a093-f6efebdc2f6f

Use it

Look up 53746-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53746-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53746-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.